General Infectious Disease News Articles

Infectious Dis.

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ehrlich HJ et al. – The prime–boost regimen resulted in antibody responses against clade 1, 2.1, 2.2, and 2.3 viruses that were significantly higher than those after the priming regimen. These findings demonstrate that a prime–boost regimen may alleviate vaccine supply constraints in a pandemic.

Related Articles

CDC Survey Shows Gains in Overall Adolescent Vaccination Rates for 2008. But Majority Still Lack Immunizations for Tdap, MCV4
American Family Physician, 10/23/09    Relevance Score: 99%

A survey of adolescent experiences of human papillomavirus vaccination in the Manchester study
British Journal of Cancer, 10/09/09    Relevance Score: 97%

One Dose of H1N1 Vaccine Immunogenic in High Percentage of Youth Ages 10 to 17. Younger Children Likely Will Need Two Doses
American Family Physician, 10/05/09    Relevance Score: 97%

Human Papillomavirus Vaccine Uptake, Predictors of Vaccination, and Self-Reported Barriers to Vaccination
Journal of Women's Health, 10/05/09    Relevance Score: 96%

H1N1 Vaccine Deliveries Begin. Early Doses to Arrive This Week
American Family Physician, 10/07/09    Relevance Score: 95%

Today in Basic Science/Genetics...keeping you current

The regulatory role of the MisR/S two-component system in hemoglobin utilization in Neisseria meningitidis
Infection and Immunity, 12/17/09

Helicobacter pylori oipA, vacA and dupA genetic diversity in individual hosts
Journal of Medical Microbiology, 12/17/09

The chemokine CXCL13 in acute neuroborreliosis
Journal of Neurology, Neurosurgery, and Psychiatry , 12/17/09

Today in Vaccine/Immunotherapy...keeping you current

Response to a Monovalent 2009 Influenza A (H1N1) Vaccine
New England Journal of Medicine, 12/17/09

A Novel Influenza A (H1N1) Vaccine in Various Age Groups
New England Journal of Medicine, 12/17/09

Trial of 2009 Influenza A (H1N1) Monovalent MF59-Adjuvanted Vaccine
New England Journal of Medicine, 12/17/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address